Concepedia

Publication | Open Access

Different Effects of Antihypertensive Therapies Based on Losartan or Atenolol on Ultrasound and Biochemical Markers of Myocardial Fibrosis

DOIFull Paper Access

153

Citations

27

References

2004

Year

Michele M. Ciulla, Roberta Paliotti, Arturo Esposito, Begoña López, Björn Dahlöf, M. Gary Nicholls, Ronald D. Smith, Leen Gilles, Fabio Magrini, Alberto Zanchetti
Circulation

Abstract

In hypertensive patients with LVH, losartan decreases myocardial collagen content, whereas atenolol does not. The difference between the 2 treatments is statistically significant.

References

YearCitations

Page 1